Application 020098

Type
NDA
Sponsor
ABBVIE

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MIVACRONMIVACURIUM CHLORIDESOLUTION;INTRAVENOUSEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERMIVACURIUM CHLORIDEINJECTABLE;INJECTIONEQ 0.5MG BASE/MLNoNo
003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERMIVACURIUM CHLORIDEINJECTABLE;INJECTIONEQ 50MG BASE/100MLNoNo
004MIVACRONMIVACURIUM CHLORIDESOLUTION;INTRAVENOUSEQ 10MG BASE/5ML (EQ 2MG BASE/ML)YesNo
005MIVACRONMIVACURIUM CHLORIDESOLUTION;INTRAVENOUSEQ 20MG BASE/10ML (EQ 2MG BASE/ML)YesNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 44.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N020098-001MIVACRONMIVACURIUM CHLORIDEEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-22
N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERMIVACURIUM CHLORIDEEQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22
N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINERMIVACURIUM CHLORIDEEQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22
N020098-004MIVACRONMIVACURIUM CHLORIDEEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22
N020098-005MIVACRONMIVACURIUM CHLORIDEEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 5 of 6 · 220 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2023-12-20 04:57 UTC2023-12N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-22ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22ea1830bbd6c7…
2023-12-20 04:57 UTC2023-12N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-22a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22a72a2bbeb626…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-229b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-229b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-229b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-229b2671bbb829…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-229b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-22a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22a67488948f0b…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-223f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-223f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-223f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-223f0d92c62455…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-223f0d92c62455…
2023-05-13 08:27 UTC2023-05N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-22053a50430f4f…
2023-05-13 08:27 UTC2023-05N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-22053a50430f4f…
2023-05-13 08:27 UTC2023-05N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-22053a50430f4f…
2023-05-13 08:27 UTC2023-05N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22053a50430f4f…
2023-05-13 08:27 UTC2023-05N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-22053a50430f4f…
2023-01-26 05:58 UTC2023-01N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-223bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-223bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-223bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-223bdfa0b2c4d7…
2023-01-26 05:58 UTC2023-01N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-223bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020098-001MIVACRONEQ 2MG BASE/ML (EQ 2MG BASE/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**SOLUTION / INTRAVENOUSRLD1992-01-223a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020098-002MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 0.5MG BASE/MLINJECTABLE / INJECTION1992-01-223a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020098-003MIVACRON IN DEXTROSE 5% IN PLASTIC CONTAINEREQ 50MG BASE/100MLINJECTABLE / INJECTION1992-01-223a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020098-004MIVACRONEQ 10MG BASE/5ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-223a93d1ddd44b…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11N020098-005MIVACRONEQ 20MG BASE/10ML (EQ 2MG BASE/ML)SOLUTION / INTRAVENOUSRLD1992-01-223a93d1ddd44b…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
55044SUPPL2018-07-30
55026SUPPL2018-07-27
12210SUPPL2015-02-03
2016SUPPL2010-11-30
34260SUPPL2010-11-22
34259SUPPL2004-06-09
21148SUPPL2004-06-09
2015SUPPL2002-06-04
41143SUPPL2000-07-03